These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance. Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I Elife; 2021 Aug; 10():. PubMed ID: 34402426 [TBL] [Abstract][Full Text] [Related]
4. SperoPredictor: An Integrated Machine Learning and Molecular Docking-Based Drug Repurposing Framework With Use Case of COVID-19. Ahmed F; Lee JW; Samantasinghar A; Kim YS; Kim KH; Kang IS; Memon FH; Lim JH; Choi KH Front Public Health; 2022; 10():902123. PubMed ID: 35784208 [TBL] [Abstract][Full Text] [Related]
5. Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors. Fiorucci D; Milletti E; Orofino F; Brizzi A; Mugnaini C; Corelli F J Biomol Struct Dyn; 2021 Oct; 39(16):6242-6248. PubMed ID: 32705942 [TBL] [Abstract][Full Text] [Related]
6. Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study. Wang J J Chem Inf Model; 2020 Jun; 60(6):3277-3286. PubMed ID: 32315171 [TBL] [Abstract][Full Text] [Related]
7. Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach. Gelemanović A; Vidović T; Stepanić V; Trajković K Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33504008 [TBL] [Abstract][Full Text] [Related]
8. In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2. Deshpande RR; Tiwari AP; Nyayanit N; Modak M Eur J Pharmacol; 2020 Nov; 886():173430. PubMed ID: 32758569 [TBL] [Abstract][Full Text] [Related]
9. Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate? Saha S; Halder AK; Bandyopadhyay SS; Chatterjee P; Nasipuri M; Bose D; Basu S Methods; 2022 Jul; 203():564-574. PubMed ID: 34455072 [TBL] [Abstract][Full Text] [Related]
10. Participation of Single-Nucleotide Variants in López-Bielma MF; Falfán-Valencia R; Abarca-Rojano E; Pérez-Rubio G Pathogens; 2023 Nov; 12(11):. PubMed ID: 38003785 [TBL] [Abstract][Full Text] [Related]
11. Drug repurposing of FDA-approved anti-viral drugs via computational screening against novel 6M03 SARS-COVID-19. Waseem W; Zafar R; Jan MS; Alomar TS; Almasoud N; Rauf A; Khattak H Ir J Med Sci; 2024 Feb; 193(1):73-83. PubMed ID: 37515684 [TBL] [Abstract][Full Text] [Related]
12. Computational Drug Repurposing for Alzheimer's Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies. Xu Y; Kong J; Hu P Front Pharmacol; 2021; 12():617537. PubMed ID: 34276354 [No Abstract] [Full Text] [Related]
13. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19. Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089 [TBL] [Abstract][Full Text] [Related]
14. Genome-wide association studies of COVID-19: Connecting the dots. Ferreira LC; Gomes CEM; Rodrigues-Neto JF; Jeronimo SMB Infect Genet Evol; 2022 Dec; 106():105379. PubMed ID: 36280088 [TBL] [Abstract][Full Text] [Related]
17. In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19. Mirmohammadi S; Kianmehr A; Sabbaghian A; Mohebbi A; Shahbazmohammadi H; Sheykharabi M; Bazzi Z Infect Genet Evol; 2022 Sep; 103():105318. PubMed ID: 35718334 [TBL] [Abstract][Full Text] [Related]
18. An overview of human proteins and genes involved in SARS-CoV-2 infection. Jahanafrooz Z; Chen Z; Bao J; Li H; Lipworth L; Guo X Gene; 2022 Jan; 808():145963. PubMed ID: 34530086 [TBL] [Abstract][Full Text] [Related]
19. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods. Ebrahimi M; Karami L; Alijanianzadeh M Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285 [TBL] [Abstract][Full Text] [Related]
20. Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation. Dai Y; Wang J; Jeong HH; Chen W; Jia P; Zhao Z Hum Genet; 2021 Sep; 140(9):1313-1328. PubMed ID: 34155559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]